Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 3056 participants.

Also called NCT02494895

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 3,056 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02494895
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02494895. Randomized; no masking; primary purpose treatment. Start 2015-08-01 (actual); primary completion 2023-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)
Condition
Acute Coronary Syndrome
Intervention (Drug)
Ticagrelor monotherapy
Intervention (Drug)
Ticagrelor with Aspirin DAPT(dual antiplatelet treatment)
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct02494895
Content hash
c6558143f322342fa81443a3a151f3834fe3672b58b97ced9a8937b3a306c648